Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Cardio-esophageal Junction of Stomach”

175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 175 results

Testing effectiveness (Phase 2)WithdrawnNCT03592407
What this trial is testing

Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT03416244
What this trial is testing

Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal CancerOesophageal CancerOesophageal Cancer Metastatic+5 more
AIO-Studien-gGmbH 66
Testing effectiveness (Phase 2)Study completedNCT04099641
What this trial is testing

An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients

Who this might be right for
Gastric CancerGastroEsophageal Cancer
OncXerna Theraputics, Inc. 80
Not applicableLooking for participantsNCT05644431
What this trial is testing

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Who this might be right for
GastroEsophageal Cancer
Centre Leon Berard 50
Testing effectiveness (Phase 2)Study completedNCT01611857
What this trial is testing

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

Who this might be right for
Malignant Solid TumourGastroesophageal Cancer
SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Large-scale testing (Phase 3)Active Not RecruitingNCT04950322
What this trial is testing

A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastric or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 737
Early research (Phase 1)Ended earlyNCT03125200
What this trial is testing

Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression

Who this might be right for
Breast CancerNon Small Cell Lung CancerGastroEsophageal Cancer+1 more
ADC Therapeutics S.A. 21
Testing effectiveness (Phase 2)Study completedNCT03165994
What this trial is testing

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Esophageal CancerGastroEsophageal Cancer
Apexigen America, Inc. 34
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableLooking for participantsNCT04455282
What this trial is testing

CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1

Who this might be right for
Cancer of EsophagusEsophagogastric Junction Disorder
Heinrich-Heine University, Duesseldorf 100
Testing effectiveness (Phase 2)Looking for participantsNCT04379596
What this trial is testing

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

Who this might be right for
Gastric Cancer
AstraZeneca 413
Large-scale testing (Phase 3)Study completedNCT02898077
What this trial is testing

Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Eli Lilly and Company 440
Early research (Phase 1)Study completedNCT04074343
What this trial is testing

TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroEsophageal Cancer
University of California, Irvine 20
Not applicableLooking for participantsNCT06138223
What this trial is testing

The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)

Who this might be right for
GastroEsophageal CancerIncurable Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 196
Testing effectiveness (Phase 2)Study completedNCT02317991
What this trial is testing

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Cancer
SCRI Development Innovations, LLC 65
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Not applicableActive Not RecruitingNCT06922279
What this trial is testing

First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled Trial

Who this might be right for
Gastroesophageal Cancer (GC)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 108
Not applicableUnknownNCT03613142
What this trial is testing

Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Peking University Cancer Hospital & Institute 202
Load More Results